Our Master of Science in Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation prepares graduates to take on Researcher, Technician, Scientist, or similar roles, particularly for employers focused on psychedelic, entheogen, and cannabinoid research. These industries are expected to grow by approximately 20% each year for the next decade, with market values exceeding $100 billion. An exemplar, partial listing of public companies focused on these areas is included below.
Furthermore, we expect that graduates will also be well positioned to seek employment in governmental or regulatory positions, as well as to pursue careers in established not-for-profit institutes and academic centers focused on psychedelic research.
- Compass Pathways (NASDAQ: CMPS)
- MindMed (NEO: MMED)
- Cybin Corp (NEO: CYBN)
- Field Trip Health, Inc. (CSE: FTRP)
- Revive Therapeutics Ltd. (CSE: RVV)
- Numinus (TSXV: NUMI)
- HAVN Life Sciences (CSE: HAVN)
- Mydecine Innovations Group (CSE: MYCO)
- Red Light Holland (CSE: TRIP)
- Champignon Brands Inc. (CSE: SHRM)
- Mind Cure Health Inc. (CSE: MCUR)
- Entheon Biomedical (CSE: ENBI)
- Better Plant Sciences (CSE: PLNT)
- Tryp Therapeutics (CSE: TRYP)
- New Wave Holdings (CSE: SPOR)
- Aion Therapeutic (CSE: AION)
- Lobe Sciences (CSE: LOBE)
- PharmaTher (CSE: PHRM)
- Hollister Biosciences (CSE: HOLL)
- Ehave Inc (OTC: EHVVF)
- Mindset Pharma (CSE: MSET)
- M2BIO (OTC: WUHN)
- Neonmind Biosciences (CSE: NEON)
- Roadman Investments Corp. (TSXV: LITT)
- Novamind (CSE: NM)
- Akerna Corp (NASDAQ:KERN)
- Aphria Inc (NYSE:APHA)
- Arena Pharmaceuticals (NASDAQ:ARNA)
- Aurora Cannabis Inc (NYSE:ACB)
- Canopy Growth Corp (NYSE:CGC)
- cbdMD Inc (NYSE:YCBD)
- Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP)
- Cronos Group Inc (NASDAQ:CRON)
- FSD Pharma Inc. (NASDAQ:HUGE)
- Greenlane Holdings, Inc. (NASDAQ:GNLN)
- GW Pharmaceuticals PLC (NASDAQ:GWPH)
- HEXO Corp (NYSE:HEXO)
- Innovative Industrial Properties Inc (NYSE:IIPR)
- Intec Pharma Ltd. (NASDAQ:NTEC)
- NEWAGE (NASDAQ:NBEV)
- OrganiGram Holdings Inc (NASDAQ:OGI)
- Pyxus International Inc (NYSE:PYX)
- Sundial Growers Inc. (NASDAQ:SNDL)
- Therapix Biosciences Ltd (NASDAQ:TRPX)
- Tilray Inc (NASDAQ:TLRY)
- 22nd Century Group, Inc. (NYSE: XXII)
- Village Farms International, Inc. (NASDAQ:VFF)
- Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE)